Sort
130,381 grants matching “hiv”
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM
$1,595,193Rebecca Schnall · Columbia University Health Sciences · U01 · FY2016 · MD
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,594,408Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2007 · AI
Production Of HIV And HIV Related Proteins For Structural Studies
$1,594,168Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2024 · AR
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$1,594,015Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI
Health and Aging in Africa: Longitudinal Studies of an INDEPTH Community
$1,593,852Lisa F Berkman · Harvard School Of Public Health · P01 · FY2020 · AG
HIV/STD Risk Reduction For African American Couples
$1,593,737University Of Pennsylvania · U10 · FY2005 · MH
Prevention of AIDS
$1,593,708Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Center for Alcohol/HIV Innovations and Biomarker Research (CALIBER)
$1,593,618Judith Alissa Hahn · University Of California, San Francisco · P60 · FY2025 · AA
PS10-10138, EXPANDED HIV TESTING FOR DISPROPORTIONATELY AFFECTED POPULATIONS
$1,593,505William Wong · Chicago Department Of Public Health · U62 · FY2010 · PS
Protein Structure
$1,593,257Alexander Wlodawer · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Identifying correlates of protection afforded by (Delta)GY SIVmac239 attenuated virus vaccine
$1,593,039Pyone Aye · Tulane University Of Louisiana · N01 · FY2017 · AI
GH15-1564, Mozambique: Increasing Access to HIV Prevention, Care and Treatment Services for Key Populations in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR)
$1,592,650Mahomed Mobaracaly · Pathfinder International, Inc. · U2G · FY2015 · GH
Production Of HIV And HIV Related Proteins For Structural Studies
$1,592,641Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2020 · AR
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy
$1,592,560Steven Daniel Douglas · Children'S Hosp Of Philadelphia · P01 · FY2008 · MH
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$1,591,967Catherine C McGowan · Vanderbilt University · U01 · FY2012 · AI
Manufacturing and Regulatory Support of Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,591,960Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2013 · AI
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)
$1,591,670James Dennis Neaton · University Of Minnesota · U01 · FY2009 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,591,480University Of Washington · U01 · FY2004 · AI
A preclinical assessment of monthly intramuscular GSK1265744, an InSTI, as PrEP
$1,591,251Martin H Markowitz · Aaron Diamond Aids Research Center · R01 · FY2013 · AI
Monitoring SIV Reservoirs with Whole Body immunoPET
$1,590,807Francois J Villinger · University Of Louisiana At Lafayette · R01 · FY2017 · AI
Human Papillomavirus (HPV) Natural History, Genomics and Risk Assessment
$1,590,643Mark Schiffman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Production of Alternate Adenovector Filovirus Vaccines
$1,590,341Kimberly Wallace · Niaid Extramural Activities · Z01 · FY2007 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,590,226Sigga Jagne · Ky St Cabinet/Health/Family Services · U62 · FY2013 · PS
Center for AIDS Research (CFAR)
$1,590,143Harris Goldstein · Albert Einstein College Of Medicine · P30 · FY2007 · AI
NHGRI/DIR Technology Transfer Program
$1,590,131Daniel Kastner · National Human Genome Research Institute · ZIK · FY2011 · HG